London Calling 2026 - Speakers
Speakers
Check out the line up of speakers at London Calling 2026.
Oxford Nanopore Technologies
Kimberley Billingsley
- Job title
- Institution
- National Institutes of Health, USA
- Biography
Kimberley Billingsley is leading the Applied Neurogenomics team at the National Institutes of Health (NIH) Center for Alzheimer’s and Related Dementias. Her work focuses on generating large-scale high-value datasets to study the impact of structural variants and tandem repeats in neurodegenerative diseases. Kimberley obtained her PhD from the University of Liverpool studying the role of transposable elements in Parkinson's disease.
- Recent publications
Akçimen, F. et al. Long-read sequencing identifies FGF14 repeat expansions in Parkinson's disease. Brain awaf456 (2025).
DOI: 10.1093/brain/awaf456Grant, S. M. et al. Long-Read epigenetic clocks identify improved brain aging predictions. bioRxiv 679553 (2025).
DOI: 10.1101/2025.09.30.679553Genner, R.M. et al. Haplotype-Resolved DNA Methylation at the APOE Locus identifies Allele-Specific Epigenetic Signatures Relevant to Alzheimer's Disease Risk. bioRxiv 662592 (2025).
DOI: 10.1101/2025.07.01.662592Billingsley, K.J. et al. Long-read sequencing of hundreds of diverse brains provides insight into the impact of structural variation on gene expression and DNA methylation. bioRxiv 628723 (2024).
DOI: 10.1101/2024.12.16.628723
Talks at this conference
Oxford Nanopore Technologies products are RUO. Products labelled/branded as Oxford Nanopore Diagnostics may be RUO or may be regulated as in-vitro diagnostic devices in some jurisdictions, please check individual product labelling. Oxford Nanopore Technologies present the materials of third parties within the user community acknowledging that those materials belong to and are the true statements and representations of those third parties. Oxford Nanopore Technologies make no endorsements of the materials shown and the statements made.
